Literature DB >> 2334681

Structural comparison of anticancer drug-DNA complexes: adriamycin and daunomycin.

C A Frederick1, L D Williams, G Ughetto, G A van der Marel, J H van Boom, A Rich, A H Wang.   

Abstract

The anticancer drugs adriamycin and daunomycin have each been crystallized with the DNA sequence d(CGATCG) and the three-dimensional structures of the complexes solved at 1.7- and 1.5-A resolution, respectively. These antitumor drugs have significantly different clinical properties, yet they differ chemically by only the additional hydroxyl at C14 of adriamycin. In these complexes the chromophore is intercalated at the CpG steps at either end of the DNA helix with the amino sugar extended into the minor groove. Solution of the structure of daunomycin bound to d(CGATCG) has made it possible to compare it with the previously reported structure of daunomycin bound to d(CGTACG). Although the two daunomycin complexes are similar, there is an interesting sequence dependence of the binding of the amino sugar to the A-T base pair outside the intercalation site. The complex of daunomycin with d(CGATCG) has tighter binding than the complex with d(CGTACG), leading us to infer a sequence preference in the binding of this anthracycline drug. The structures of daunomycin and adriamycin with d(CGATCG) are very similar. However, there are additional solvent interactions with the adriamycin C14 hydroxyl linking it to the DNA. Surprisingly, under the influence of the altered solvation, there is considerable difference in the conformation of spermine in these two complexes. The observed changes in the overall structures of the ternary complexes amplify the small chemical differences between these two antibiotics and provide a possible explanation for the significantly different clinical activities of these important drugs.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2334681

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  100 in total

1.  The crystal structure of the complex between a disaccharide anthracycline and the DNA hexamer d(CGATCG) reveals two different binding sites involving two DNA duplexes.

Authors:  Claudia Temperini; Luigi Messori; Pierluigi Orioli; Cristina Di Bugno; Fabio Animati; Giovanni Ughetto
Journal:  Nucleic Acids Res       Date:  2003-03-01       Impact factor: 16.971

2.  Hydropathic analysis of the free energy differences in anthracycline antibiotic binding to DNA.

Authors:  Derek J Cashman; J Neel Scarsdale; Glen E Kellogg
Journal:  Nucleic Acids Res       Date:  2003-08-01       Impact factor: 16.971

3.  Ternary interactions of spermine with DNA: 4'-epiadriamycin and other DNA: anthracycline complexes.

Authors:  L D Williams; C A Frederick; G Ughetto; A Rich
Journal:  Nucleic Acids Res       Date:  1990-09-25       Impact factor: 16.971

4.  Preparation and biomedical applications of programmable and multifunctional DNA nanoflowers.

Authors:  Yifan Lv; Rong Hu; Guizhi Zhu; Xiaobing Zhang; Lei Mei; Qiaoling Liu; Liping Qiu; Cuichen Wu; Weihong Tan
Journal:  Nat Protoc       Date:  2015-09-10       Impact factor: 13.491

5.  Nanodrug Formed by Coassembly of Dual Anticancer Drugs to Inhibit Cancer Cell Drug Resistance.

Authors:  Yuanyuan Zhao; Fei Chen; Yuanming Pan; Zhipeng Li; Xiangdong Xue; Chukwunweike Ikechukwu Okeke; Yifeng Wang; Chan Li; Ling Peng; Paul C Wang; Xiaowei Ma; Xing-Jie Liang
Journal:  ACS Appl Mater Interfaces       Date:  2015-08-19       Impact factor: 9.229

6.  The molecular structure of a 4'-epiadriamycin complex with d(TGATCA) at 1.7A resolution: comparison with the structure of 4'-epiadriamycin d(TGTACA) and d(CGATCG) complexes.

Authors:  B Langlois d'Estaintot; B Gallois; T Brown; W N Hunter
Journal:  Nucleic Acids Res       Date:  1992-07-25       Impact factor: 16.971

7.  Measurement of the binding of DNA to liposomes by resonance energy transfer.

Authors:  A Köiv; P K Kinnunen
Journal:  J Fluoresc       Date:  1994-12       Impact factor: 2.217

8.  A new bisintercalating anthracycline with picomolar DNA binding affinity.

Authors:  José Portugal; Derek J Cashman; John O Trent; Neus Ferrer-Miralles; Teresa Przewloka; Izabela Fokt; Waldemar Priebe; Jonathan B Chaires
Journal:  J Med Chem       Date:  2005-12-29       Impact factor: 7.446

9.  A novel assay for drug-DNA binding mode, affinity, and exclusion number: scanning force microscopy.

Authors:  J E Coury; L McFail-Isom; L D Williams; L A Bottomley
Journal:  Proc Natl Acad Sci U S A       Date:  1996-10-29       Impact factor: 11.205

10.  Promoter-specific inhibition of transcription by daunorubicin in Saccharomyces cerevisiae.

Authors:  Silvia Marín; Sylvia Mansilla; Natàlia García-Reyero; Marta Rojas; José Portugal; Benjamin Piña
Journal:  Biochem J       Date:  2002-11-15       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.